000 01169 a2200325 4500
005 20250516101536.0
264 0 _c20121203
008 201212s 0 0 eng d
022 _a1473-5571
024 7 _a10.1097/QAD.0b013e3283546623
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aCambiano, Valentina
245 0 0 _aThe role of individual-based models in understanding the potential impact of antiretroviral therapy for prevention.
_h[electronic resource]
260 _bAIDS (London, England)
_cJul 2012
300 _a1441-2 p.
_bdigital
500 _aPublication Type: Editorial
650 0 4 _aAcquired Immunodeficiency Syndrome
_xdrug therapy
650 0 4 _aAnti-HIV Agents
_xadministration & dosage
650 0 4 _aCD4 Lymphocyte Count
650 0 4 _aCost-Benefit Analysis
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aPractice Guidelines as Topic
650 0 4 _aPrevalence
650 0 4 _aRNA, Viral
_xdrug effects
700 1 _aPhillips, Andrew N
773 0 _tAIDS (London, England)
_gvol. 26
_gno. 11
_gp. 1441-2
856 4 0 _uhttps://doi.org/10.1097/QAD.0b013e3283546623
_zAvailable from publisher's website
999 _c21922322
_d21922322